A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 19
[Display Entries]
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : GC
Long Form : genomic classifier
No. Year Title Co-occurring Abbreviation
2019 Genomic Classifier for Guiding Treatment of Intermediate-Risk Prostate Cancers to Dose-Escalated Image Guided Radiation Therapy Without Hormone Therapy. ADT, CI, IR-PCa, NCCN, RT
2019 Genomic Risk Predicts Molecular Imaging-detected Metastatic Nodal Disease in Prostate Cancer. CAPRA, NCCN, OR, PCa, PET
2019 Long non-coding RNAs identify a subset of luminal muscle-invasive bladder cancer patients with favorable prognosis. lncRNAs, LP, LPL-C3, MIBC, mRNA, NAC, RC
2019 Prospective study to define the clinical utility and benefit of Decipher testing in men following prostatectomy. ART
2019 Validation of a genomic classifier for prediction of metastasis and prostate cancer-specific mortality in African-American men following radical prostatectomy in an equal access healthcare setting. AAM, PC, PCSM, RP
2018 Analytical performance of the ThyroSeq v3 genomic classifier for cancer diagnosis in thyroid nodules. FNA
2018 Validation of a Genomic Risk Classifier to Predict Prostate Cancer-specific Mortality in Men with Adverse Pathologic Features. AUC, BCR2, CAPRA-S, MET, PCSM, PCSM10, RP
2017 Cost-effectiveness of the Decipher Genomic Classifier to Guide Individualized Decisions for Early Radiation Therapy After Prostatectomy for Prostate Cancer. QALYs
2017 Utilization of biopsy-based genomic classifier to predict distant metastasis after definitive radiation and short-course ADT for intermediate and high-risk prostate cancer. ADT, MVA, NCCN, UVA
10  2016 Utilization of a Genomic Classifier for Prediction of Metastasis Following Salvage Radiation Therapy after Radical Prostatectomy. PCa, RP, SRT
11  2015 Combined value of validated clinical and genomic risk stratification tools for predicting prostate cancer mortality in a high-risk prostatectomy cohort. C-index, CAPRA-S, CI, CSM, HRs, RP
12  2015 Effect of a genomic classifier test on clinical practice decisions for patients with high-risk prostate cancer after surgery. ART, PSMs, RP
13  2015 Genomic classifier identifies men with adverse pathology after radical prostatectomy who benefit from adjuvant radiation therapy. RP, RT
14  2015 Impact of a Genomic Classifier of Metastatic Risk on Postprostatectomy Treatment Recommendations by Radiation Oncologists and Urologists. CI
15  2014 A genomic classifier predicting metastatic disease progression in men with biochemical recurrence after prostatectomy. BCR, GS, PSADT, ROC, RP, ttBCR
16  2014 Genomic prostate cancer classifier predicts biochemical failure and metastases in patients after postoperative radiation therapy. BF, DM, RP, RT
17  2014 Influence of a genomic classifier on post-operative treatment decisions in high-risk prostate cancer patients: results from the PRO-ACT study. DCS, RP
18  2013 Discovery and validation of a prostate cancer genomic classifier that predicts early metastasis following radical prostatectomy. ---
19  2013 Impact of a genomic classifier of metastatic risk on postoperative treatment recommendations for prostate cancer patients: a report from the DECIDE study group. BCR, RP